Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Secondary Progressive Multiple Sclerosis
NCT00647348Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Jan 2008
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in secondary-progressive multiple sclerosis (SPMS) comparing Simvastatin with Placebo (2 arms). Primary endpoint: Percentage Change in Whole Brain Volume at 24 months. Started Jan 2008; status: completed.
02
Drugs
simvastatin
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT00647348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00647348.